Two Human Immunodeficiency Virus Vaccinal Lipopeptides Follow Different Cross-Presentation Pathways in Human Dendritic Cells

An efficient vaccine against human immunodeficiency virus (HIV) must induce good cellular immune responses. To do this, it must be processed and presented by dendritic cells, which are required for primary T-lymphocyte stimulation. We have previously shown that a model lipopeptide containing a short...

詳細記述

書誌詳細

出版年:	J Virol
主要な著者:	Andrieu, Muriel, Desoutter, Jean-François, Loing, Estelle, Gaston, Jésintha, Hanau, Daniel, Guillet, Jean-Gérard, Hosmalin, Anne
フォーマット:	Artigo
言語:	Inglês
出版事項:	American Society for Microbiology (ASM) 2003
主題:	Virus-Cell Interactions
オンライン･アクセス:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC140847/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/12502869/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/JVI.77.2.1564-1570.2003
タグ:	タグ追加 タグなし, このレコードへの初めてのタグを付けませんか!